Synthesizing a Contrast-Enhancement Map in Patients with High-Grade Gliomas Based on a Postcontrast MR Imaging Quantification Only

References

1. 1.↵
   2. Ellingson BM,
   3. Bendszus M,
   4. Sorensen AG, et al

   . Emerging techniques and technologies in brain tumor imaging. Neuro Oncol 2014;16(Suppl 7):vii12–23 doi:10.1093/neuonc/nou221 pmid:25313234

   CrossRefPubMed
2. 2.↵
   2. Ellingson BM,
   3. Harris RJ,
   4. Woodworth KL

   . Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single- and multicenter trials. Neuro Oncol 2017;19:89–98 doi:10.1093/neuonc/now187 pmid:27580889

   CrossRefPubMed
3. 3.↵
   2. Claes A,
   3. Idema AJ,
   4. Wesseling P

   . Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007;114:443–58 doi:10.1007/s00401-007-0293-7 pmid:17805551

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Zhu DC,
   3. Penn RD

   . Full-brain T1 mapping through inversion recovery fast spin echo imaging with time-efficient slice ordering. Magn Reson Med 2005;54:725–31 doi:10.1002/mrm.20602 pmid:16086307

   CrossRefPubMed
5. 5.↵
   2. Neeb H,
   3. Zilles K,
   4. Shah NJ

   . A new method for fast quantitative mapping of absolute water content in vivo. Neuroimage 2006;31:1156–68 doi:10.1016/j.neuroimage.2005.12.063 pmid:16650780

   CrossRefPubMed
6. 6.↵
   2. Deoni SC,
   3. Peters TM,
   4. Rutt BK

   . High-resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2. Magn Reson Med 2005;53:237–41 doi:10.1002/mrm.20314 pmid:15690526

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Warntjes JB,
   3. Leinhard OD,
   4. West J, et al

   . Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magn Reson Med 2008;60:320–29 doi:10.1002/mrm.21635 pmid:18666127

   CrossRefPubMed
8. 8.↵
   2. Ma D,
   3. Gulani V,
   4. Seiberlich N, et al

   . Magnetic resonance fingerprinting. Nature 2013;495:187–92 doi:10.1038/nature11971 pmid:23486058

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Alfano B,
   3. Brunetti A,
   4. Arpaia M, et al

   . Multiparametric display of spin-echo data from MR studies of brain. J Magn Reson Imaging 1995;5:217–25 doi:10.1002/jmri.1880050218 pmid:7766985

   CrossRefPubMedWeb of Science
10. 10.↵
    2. Warntjes JB,
    3. Engström M,
    4. Tisell A, et al

    . Brain characterization using normalized quantitative magnetic resonance imaging. PLoS One 2013;8:e70864 doi:10.1371/journal.pone.0070864 pmid:23940653

    CrossRefPubMed
11. 11.↵
    2. Engström M,
    3. Warntjes JB,
    4. Tisell A, et al

    . Multi-parametric representation of voxel-based quantitative magnetic resonance imaging. PLoS One 2014;9:e111688 doi:10.1371/journal.pone.0111688 pmid:25393722

    CrossRefPubMed
12. 12.↵
    2. West J,
    3. Blystad I,
    4. Engström M, et al

    . Application of quantitative MRI for brain tissue segmentation at 1.5 T and 3.0 T field strengths. PLoS One 2013;8:e74795 doi:10.1371/journal.pone.0074795 pmid:24066153

    CrossRefPubMed
13. 13.↵
    2. Tanenbaum LN,
    3. Tsiouris AJ,
    4. Johnson AN, et al

    . Synthetic MRI for clinical neuroimaging: results of the Magnetic Resonance Image Compilation (MAGiC) prospective, multicenter, multireader trial. AJNR Am J Neuroradiol 2017;38:1103–10 doi:10.3174/ajnr.A5227 pmid:28450439

    Abstract/FREE Full Text
14. 14.↵
    2. Müller A,
    3. Jurcoane A,
    4. Kebir S, et al

    . Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma. Cancer Med 2017;6:89–99 doi:10.1002/cam4.966 pmid:27891815

    CrossRefPubMed
15. 15.↵
    2. Lescher S,
    3. Jurcoane A,
    4. Veit A, et al

    . Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI. Neuroradiology 2015;57:11–20 doi:10.1007/s00234-014-1445-9 pmid:25287076

    CrossRefPubMed
16. 16.↵
    2. Blystad I,
    3. Warntjes JBM,
    4. Smedby Ö, et al

    . Quantitative MRI for analysis of peritumoral edema in malignant gliomas. PLoS One 2017;12:e0177135 doi:10.1371/journal.pone.0177135 pmid:28542553

    CrossRefPubMed
17. 17.↵
    2. Ellingson BM,
    3. Kim HJ,
    4. Woodworth DC, et al

    . Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology 2014;271:200–10 doi:10.1148/radiol.13131305 pmid:24475840

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Grabowski MM,
    3. Recinos PF,
    4. Nowacki AS, et al

    . Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 2014;121:1115–23 doi:10.3171/2014.7.JNS132449 pmid:25192475

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Chaichana KL,
    3. Jusue-Torres I,
    4. Navarro-Ramirez R, et al

    . Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol 2014;16:113–22 doi:10.1093/neuonc/not137 pmid:24285550

    CrossRefPubMed
20. 20.↵
    2. Eisele SC,
    3. Wen PY,
    4. Lee EQ

    . Assessment of brain tumor response: RANO and its offspring. Curr Treat Options Oncol 2016;17:35 doi:10.1007/s11864-016-0413-5 pmid:27262709 pmid:27262709

    CrossRefPubMed
21. 21.↵
    2. Shiroishi MS,
    3. Boxerman JL,
    4. Pope WB

    . Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma. Neuro Oncol 2016;18:467–78 doi:10.1093/neuonc/nov179 pmid:26364321

    CrossRefPubMed
22. 22.↵
    2. Lemercier P,
    3. Paz Maya S,
    4. Patrie JT, et al

    . Gradient of apparent diffusion coefficient values in peritumoral edema helps in differentiation of glioblastoma from solitary metastatic lesions. AJR Am J Roentgenol 2014;203:163–69 doi:10.2214/AJR.13.11186 pmid:24951211

    CrossRefPubMed
23. 23.↵
    2. Akbari H,
    3. Macyszyn L,
    4. Da X, et al

    . Imaging surrogates of infiltration obtained via multiparametric imaging pattern analysis predict subsequent location of recurrence of glioblastoma. Neurosurgery 2016;78:572–80 doi:10.1227/NEU.0000000000001202 pmid:26813856

    CrossRefPubMed
24. 24.↵
    2. Hygino da Cruz LC Jr.,
    3. Rodriguez I,
    4. Domingues RC, et al

    . Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 2011;32:1978–85 doi:10.3174/ajnr.A2397 pmid:21393407

    Abstract/FREE Full Text